Humanized mouse models offer a partial solution by engrafting immunodeficient mice with human CD34+ hematopoietic stem cells, peripheral blood mononuclear cells (PBMCs), or humanized-bone marrow, liver, thymus (Hu‐BLT), enabling the evaluation of human immune-tumor interactions. The gene discussed is CD34; the disease is neoplasm.